Beurswaarde Reddit verdubbeld sinds beursdebuut
De Tijd,
Maar dat lost niet alles op, schrijft Benoît van den Hove, de CEO van Euronext Brussel.
Direct targeting of IgG shows promise for ITP: study
Thelimbic,
Targeted reduction of immunoglobulin G (IgG) with efgartigimod has shown promise as a new therapeutic strategy for patients…
Efgartigimod efficacious, safe for primary immune thrombocytopenia
Today Headline,
The first-in-class novel human immunoglobulin G1 Fc fragment, efgartigimod, is efficacious and safe for patients with chronic…
Efgartigimod efficacious, safe for primary immune thrombocytopenia
MedicalXpress,
The first-in-class novel human immunoglobulin G1 Fc fragment, efgartigimod, is efficacious and safe for patients with chronic…